Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNAPSE
NCT03085797Phase 3Completed
- Sponsor
- GSK
- Start
- May 2017
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of mepolizumab in nasal polyps, sponsored by GSK. Started May 2017; status: completed.
02
Drugs
mepolizumab
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT03085797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03085797.